Suppr超能文献

[变应性鼻炎变应原免疫治疗机制的研究进展]

[The research progress of mechanism of allergen immunotherapy in allergic rhinitis].

作者信息

Kong Yonggang, Jiao Woer, Tao Zezhang, Chen Shiming

出版信息

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Dec;35(12):1149-1152. doi: 10.13201/j.issn.2096-7993.2021.12.021.

Abstract

Allergic rhinitis(AR) is a chronic non-infectious nasal mucosal disease mediated by IgE. It can be divided into seasonal and perennial according to the types of allergens.At present, there are many treatments for AR, among which allergen immunotherapy(AIT) is the only treatment option that can change the natural process of AR.AIT can improve innate immune response by reducing local hypertrophy, eosinophils, basophils and type 2 innate lymphocytes, and affect various T cells, B cells and many cytokines to regulate adaptive immunity. The mechanism of AIT on immune response is complex.In this review, the mechanism of immunotherapy on the innate and adaptive immunity of AR patients is highlighted, hoping to further understand the immunotherapy pathway of AR, and provide more theoretical basis for immunotherapy of AR.

摘要

变应性鼻炎(AR)是一种由IgE介导的慢性非感染性鼻黏膜疾病。根据变应原类型可分为季节性和常年性。目前,AR有多种治疗方法,其中变应原免疫疗法(AIT)是唯一能够改变AR自然病程的治疗选择。AIT可通过减少局部肥大、嗜酸性粒细胞、嗜碱性粒细胞和2型固有淋巴细胞来改善固有免疫反应,并影响各种T细胞、B细胞和多种细胞因子以调节适应性免疫。AIT对免疫反应的机制很复杂。在本综述中,重点阐述了免疫疗法对AR患者固有免疫和适应性免疫的机制,希望进一步了解AR的免疫治疗途径,并为AR的免疫治疗提供更多理论依据。

相似文献

1
[The research progress of mechanism of allergen immunotherapy in allergic rhinitis].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Dec;35(12):1149-1152. doi: 10.13201/j.issn.2096-7993.2021.12.021.
2
[Research progress of immune cell markers in allergic rhinitis for the evaluation of allergen immunotherapy].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Mar;38(3):251-255;260. doi: 10.13201/j.issn.2096-7993.2024.03.014.
3
Mechanisms of Allergen Immunotherapy in Allergic Rhinitis.
Curr Allergy Asthma Rep. 2020 Dec 12;21(1):2. doi: 10.1007/s11882-020-00977-7.
4
Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma.
J Allergy Clin Immunol. 2022 Mar;149(3):791-801. doi: 10.1016/j.jaci.2022.01.016. Epub 2022 Jan 29.
6
Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens.
J Allergy Clin Immunol. 2014 Mar;133(3):621-31. doi: 10.1016/j.jaci.2013.12.1088.
7
Clinical efficacy of immunotherapy in allergic rhinitis.
Am J Rhinol Allergy. 2016 Sep 1;30(5):4-7. doi: 10.2500/ajra.2016.30.4368.
9
Clinical efficacy of immunotherapy in allergic rhinitis.
Am J Rhinol Allergy. 2016 Sep 1;30(5):4-7. doi: 10.2500/ajra.2016.30.4368.
10
Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers.
J Allergy Clin Immunol. 2017 Dec;140(6):1485-1498. doi: 10.1016/j.jaci.2017.10.010.

引用本文的文献

1
[Mechanism of Der f 1/IGF-1 nanoparticle promoting the production of regulatory T cell].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Apr;37(4):272-277. doi: 10.13201/j.issn.2096-7993.2023.04.007.
2
[Profiles of IgE sensitization to dust mite allergen components in patients with allergic rhinitis and asthma].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Aug;36(8):576-581. doi: 10.13201/j.issn.2096-7993.2022.08.002.

本文引用的文献

1
CD23 expression on switched memory B cells bridges T-B cell interaction in allergic rhinitis.
Allergy. 2020 Oct;75(10):2599-2612. doi: 10.1111/all.14288. Epub 2020 Apr 14.
3
[Effect of sublingual immunotherapy with Dermatophagoides Farinae on the expression of specific IgG4 in patients with allergic rhinitis in Hainan area].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Feb;34(2):135-139. doi: 10.13201/j.issn.1001-1781.2020.02.009.
4
Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: A randomized controlled trial.
Allergy. 2020 Aug;75(8):2026-2036. doi: 10.1111/all.14218. Epub 2020 Feb 23.
5
Induction of IgG and IgG B-cell memory following sublingual immunotherapy for ryegrass pollen allergy.
Allergy. 2020 May;75(5):1121-1132. doi: 10.1111/all.14073. Epub 2019 Nov 4.
6
Thrombospondin 1-mediated suppression of mast cell degranulation is involved in the efficacy of sublingual immunotherapy.
Allergol Int. 2019 Sep;68S:S9-S10. doi: 10.1016/j.alit.2019.03.007. Epub 2019 Apr 25.
7
Sublingual immunotherapy alters salivary IgA and systemic immune mediators in timothy allergic children.
Pediatr Allergy Immunol. 2019 Aug;30(5):522-530. doi: 10.1111/pai.13047. Epub 2019 Apr 14.
8
Birch pollen allergen immunotherapy reprograms nasal epithelial transcriptome and recovers microbial diversity.
J Allergy Clin Immunol. 2019 Jun;143(6):2293-2296.e11. doi: 10.1016/j.jaci.2019.02.002. Epub 2019 Feb 12.
9
Immunologic modification in mono- and poly-sensitized patients after sublingual immunotherapy.
Laryngoscope. 2019 May;129(5):E170-E177. doi: 10.1002/lary.27721. Epub 2018 Dec 13.
10
Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
Allergy. 2019 May;74(5):976-985. doi: 10.1111/all.13684. Epub 2019 Jan 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验